Pharmacological therapies to minimise platelet transfusion.
Norfolk
D R
DR
The General Infirmary at Leeds, LS1 3EX, Leeds, UK.
Seghatchian
J
J
D000933:Antifibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use; D002315:Cardiopulmonary Bypass / Q000009:adverse effects; D003894:Deamino Arginine Vasopressin / Q000494:pharmacology / Q000627:therapeutic use; D005169:Factor VIII / Q000187:drug effects / Q000378:metabolism; D006470:Hemorrhage / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D017713:Platelet Transfusion / Q000009:adverse effects / Q000706:statistics & numerical data*; D006113:United Kingdom; D014667:Vasopressins / Q000627:therapeutic use; D014841:von Willebrand Factor / Q000187:drug effects / Q000378:metabolism
D000933:Antifibrinolytic Agents; D014841:von Willebrand Factor; D014667:Vasopressins; D005169:Factor VIII; D003894:Deamino Arginine Vasopressin